title: Improvement in islet yield from obese donors for human islet transplants.
abstract: BACKGROUND
  The feasibility of human islet transplantations has been firmly established. To increase the number of islet transplants, the suitability of pancreases from organ donors considered inappropriate for pancreas transplantations must be evaluated.
  
  
  METHODS
  We isolated islets from 114 human cadaver donor pancreases by the automated Ricordi method, followed by purification using continuous-density gradients. We divided the pancreases into two groups by donor body mass index (BMI)--group 1: n=51, BMI of 30 or more; group 2: n=63, BMI of less than 30. We compared the results of human islet isolation, in vitro potency assays, and a nude mouse bioassay.
  
  
  RESULTS
  In group 1 (vs. group 2), we found a significantly higher mean pancreas weight (109.5+/-30.7 vs. 90.6+/-24.0 g; P=0.0002); higher mean islet equivalents/pancreas, after digestion (442,565+/-238,741 vs. 289,860+/-158,995; P<0.0001) and after purification (319,129+/-164,002 vs. 215,753+/-126,089; P=0.0002); and a higher islet isolation success rate--defined as isolations yielding more than 300,000 islet equivalents/pancreas, with purities of more than 50% (37.3% [19 of 51 pancreases] vs. 15.9% [10 of 63]; P=0.009). Our in vitro potency assays and bioassay uncovered no differences between the two groups. Notably, all except one of the donor BMIs for the successful isolations in group 2 exceeded 26; the mean donor BMI for the successful isolations (27.3+/-3.0, n=10) was significantly higher than for the unsuccessful isolations (24.8+/-3.3, n=53) (P=0.03).
  
  
  CONCLUSIONS
  Pancreases from both overweight (BMI > or = 26 but <30) and obese (BMI > or = 30) cadaver donors are suitable for islet isolation and transplantations. Their use could increase the size of the islet donor pool.
authors.affiliation: Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA.
authors.forename: Ippei
authors.initials: I
authors.lastname: Matsumoto
authors.forename: Toshiya
authors.initials: T
authors.lastname: Sawada
authors.forename: Masahiko
authors.initials: M
authors.lastname: Nakano
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Sakai
authors.forename: Baolin
authors.initials: B
authors.lastname: Liu
authors.forename: Jeffrey D
authors.initials: JD
authors.lastname: Ansite
authors.forename: Hui-Jian
authors.initials: HJ
authors.lastname: Zhang
authors.forename: Raja
authors.initials: R
authors.lastname: Kandaswamy
authors.forename: David E R
authors.initials: DE
authors.lastname: Sutherland
authors.forename: Bernhard J
authors.initials: BJ
authors.lastname: Hering
mesh_terms: D000328:Adult; D000818:Animals; D015992:Body Mass Index; D002423:Cause of Death; D002469:Cell Separation / Q000379:methods; D005260:Female; D005947:Glucose / Q000494:pharmacology; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007328:Insulin / Q000032:analysis / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000166:cytology* / Q000378:metabolism; D008297:Male; D051379:Mice; D008819:Mice, Nude; D009765:Obesity / Q000503:physiopathology*; D012189:Retrospective Studies; D013997:Time Factors; D014019:Tissue Donors / Q000706:statistics & numerical data*; D020858:Tissue and Organ Harvesting / Q000379:methods*; D014183:Transplantation, Heterologous / Q000502:physiology
chemical_list: D007328:Insulin; D005947:Glucose